The majority of patients with cancer do not die as a result of the primary tumour, rather from the metastases that arise from that tumour. The mechanisms and markers of metastasis have, therefore, been a main focus of both clinical and preclinical research. This Perspectives article discusses the hurdles that need to be overcome to successfully translate the preclinical metastasis research into the clinic.
- François-Clément Bidard
- Jean-Yves Pierga
- Jean Paul Thiery